Did you see CNBC reports when Pfizer were completing pre clinical testing on their oral tablet?
No.
How much is their annual marketing budget compared to PAA?
Loads.
So why would you expect PAA to be on CNBC for pre clinical testing when even Pfizer aren't?
We're all tired of the PR and marketing rants. At the right time, like Pfizer, I'm sure PAA will push the button.
Not everyone is here for a short term price increase so they can trade the stock.
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-254
-
- There are more pages in this discussion • 479 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.3¢ |
Change
0.003(1.47%) |
Mkt cap ! $83.87M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.5¢ | 17.0¢ | $1.27K | 7.471K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 114661 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 277204 | 5 |
View Market Depth
| Last trade - 10.35am 20/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |